Fact based stock research
Akzo Nobel (ENXTAM:AKZA)


Akzo Nobel stock research in summary

akzonobel.com


Akzo Nobel shares have a SELL rating. While they are safely financed, they are bad value, and show below average growth. We recommend selling Akzo Nobel shares.


Latest Obermatt Ranks


Country Netherlands
Industry Specialty Chemicals
Index AEX
Size class XX-Large

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()







 

Research History: Akzo Nobel

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
61
84
58
38
STOCK GROWTH RANKS
71
23
12
8
STOCK SAFETY RANKS
81
88
50
53
COMBINED STOCK RANKS
88
82
21
17

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Akzo Nobel in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Akzo Nobel; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
65
23
16
3
PROFIT GROWTH
50
42
21
1
STOCK RETURNS
66
45
58
62
CONSOLIDATED RANK: GROWTH
71
23
12
8

Financial reporting date of Growth Rank: 31-Dec-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Akzo Nobel.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
48
50
43
42
REFINANCING
14
47
LIQUIDITY
80
96
54
53
CONSOLIDATED RANK: SAFETY
81
88
50
53

Financial reporting date of Safety Rank: 31-Dec-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Akzo Nobel and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Akzo Nobel from March 22, 2018.